Skip to main content

$4.89 0.04 (0.83%)

High

$4.91

Low

$4.84

Trades

2,189

Turnover

$12,690,360

Volume

2,597,502
30 June 2023 at 4:12pm
Register to track A2M and receive email alerts.

FDA approval to supply infant milk formula to United States

StockBot

416,823 posts

A2M released this announcement to the ASX on 3 November 2022, 7:42. The announcement is marked as price sensitive, and is 2 page(s) in length and 189.08kb in size.

You can view all announcements from A2M and see how they appear on a price chart on the announcements page.

At the date of this announcement, A2M was 3.205% short sold according to ASIC data. It was ranked the 91st most shorted stock on the ASX. It is now ranked as the 77th most shorted stock on the ASX with 3.359% of total shares short sold as of the latest reported data (05 May 2025).

Other Recent Announcements from A2M
NZX - Disclosure of Relevant Interests 15 June 2023, 11:15
NZX Capital Change Notice 13 June 2023, 11:42
Annexure to Appendix 3G 13 June 2023, 11:41
FDA approval to supply infant milk formula to United States 3 November 2022, 7:42
Company Presentation 27 October 2022, 12:07
Organisational announcement - Chief Operations Officer 25 October 2022, 7:35
Notice of Meeting and update to remuneration practices 19 October 2022, 13:38
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track A2M and receive email alerts.